Select the highest immunogenicity epitopes from oncoprotein of TCR interaction.
Therapeutic vaccines are based on specific stimulation of the immune system using antigens to elicit an immunol response.
Atom provides the end-to-end epitope selection from the ability of immunogenicity with TCR and MHC of our immunol therapeutic vaccine module. In this module, we simulation the interaction of TCR and antigen, relax side-chains and predict the affinity from current interaction structure.
We then select the highest immunogenicity epitopes to simulate and recombine epitopes structure to ensure the immunol surface from antigen sustains.